An experimental gene-editing therapy that aims to lower bad cholesterol for the long-term after a single infusion is off to a ...

Add Yahoo as a preferred source to see more of our stories on Google. Those whose cholesterol fluctuated the most had a 60% increased risk of dementia, researchers report in findings published ...

An experimental one-time gene editing therapy significantly lowered LDL cholesterol in an early-stage trial, raising hopes ...

Trials of a new cholesterol-lowering pill have shown promising results for people with heterozygous familial hypercholesterolemia (HeFH), a genetic disorder that leads to high levels of LDL ...

In a major medical breakthrough, scientists have shown that a one-time gene therapy can sharply lower "bad" cholesterol for ...

A revolutionary gene-silencing technique has shown that a single treatment can dramatically lower LDL cholesterol levels for over a year—without permanently altering DNA. Could this be the future of ...

A new study of Sardinia’s longest-living residents reveals that moderate LDL cholesterol levels may be a secret to longevity—challenging mainstream medical advice on cholesterol management. Study: The ...

Those with the greatest changes in cholesterol had a 60% increased risk of dementia They also had a 23% increased risk of mild cognitive impairment THURSDAY, Jan. 30, 2025 (HealthDay News) -- Seniors ...

Seniors whose cholesterol levels spike and plummet year-to-year could be at increased risk of dementia and failing brain health, a new study suggests. Those whose cholesterol fluctuated the most had a ...